Author

J. Kjærgaard

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial.

BACKGROUND SGLT2 inhibitors (SGLT2i) reduce mortality in left heart failure. In pulmonary arterial hypertension (PAH), preclinical data suggest SGLT2i improve right ventricular function through metabolic modulation and inhibition of vascular remodeling via smooth muscle cell pathways. The DAPAH trial evaluated whether...

M. Ersbøll, J. Kjærgaard, K. Waidtløw et al. · The Journal of Heart and Lun... · 1 citation

Open access Sep 2026

Long-term Mortality and Shock-rate in Patients Surviving Out-of-Hospital Cardiac Arrest with and without early implantation of an Implantable Cardioverter Defibrillator.

INTRODUCTION In patients who survive out-of-hospital cardiac arrest (OHCA), guidelines for implantation of an implantable cardioverter-defibrillator (ICD) are not unequivocal. METHODS Patients resuscitated from OHCA of cardiac cause, without a reversible cause and an expected survival >1 year were identified (year 20...

M. Winther-Jensen, B. T. Philbert, M. L. Laursen et al. · Scandinavian Cardiovascular... · 0 citations

Review Open access Jul 2026

Advanced Hemodynamic Monitoring During Post-Resuscitation Care After Out-of-Hospital Cardiac Arrest: A Scoping Review.

No single variable was consistently associated with prognosis or treatment response, although low SvO2 and elevated pulmonary artery pressure were associated with worse outcomes, although low SvO2 and elevated pulmonary artery pressure were associated with worse outcomes in some studies.

J. Grand, F. Lau, C. Hassager et al. · Resuscitation · 1 citation